Tag: Sickle-Cell Anemia
Risk Factors ID’d for Severe COVID-19 With Sickle Cell Disease
Hydroxyurea use does not impact development of serious COVID-19 or need for hospitalization in children or adults
Treatment at Infusion Center Beneficial in Sickle Cell Disease
Outcomes significantly better for treatment of vaso-occlusive crises at infusion center versus emergency department
Gene Therapy for Sickle Cell Did Not Cause Patient’s Leukemia
Bluebird Bio says it has not found evidence that its gene therapy caused the sickle cell patient's leukemia
Transplant Beneficial for Kidney Failure in Sickle Cell
Patients with kidney failure associated with sickle cell disease are less likely to receive a transplant despite similar reduction in mortality
Trial of Gene Therapy for Sickle Cell Disease Halted
Two patients participating in the study developed cancer years after treatment
ASH: CRISPR-Cas9 Gene Editing Promising in TDT, SCD
Total hemoglobin, fetal Hb increased in seven patients with transfusion-dependent ß-thalassemia, three with sickle cell disease
ASH: CRISPR-Cas9 Gene Editing Promising in TDT, SCD
Total hemoglobin, fetal Hb increased in five patients with transfusion-dependent ß-thalassemia, two with sickle cell disease
Medical Marijuana Tied to Fewer Admissions in Sickle Cell Disease
Endurance Exercise May Offer Vascular Benefit in Sickle Cell Disease
